OXFORD GENETICS

oxford-genetics-logo

Oxford Genetics is a UK-based biotechnology company specializing in the production of versatile cloning plasmids for research in academic and biotechnology institutions. They also provide custom cloning and DNA synthesis. All of their products are free of intellectual property restrictions.

#People #Financial #Event #Website #More

OXFORD GENETICS

Social Links:

Industry:
Biotechnology Genetics

Founded:
2011-04-28

Address:
Upper Heyford, Somerset, United Kingdom

Country:
United Kingdom

Website Url:
http://www.oxgene.com

Total Employee:
51+

Status:
Active

Contact:
+44 18 6923 8004

Email Addresses:
[email protected]

Total Funding:
16.76 M GBP

Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Cloudflare JS Microsoft Microsoft Azure Shutterstock Symantec Secure Site KnowBe4


Current Employees Featured

laura-ciccolini_image

Laura Ciccolini
Laura Ciccolini Head of Commercial Management @ Oxford Genetics
Head of Commercial Management
2022-01-01

ryan-cawood_image

Ryan Cawood
Ryan Cawood Chief Scientific Officer @ Oxford Genetics
Chief Scientific Officer
2021-03-01

leonard-seymour_image

Leonard Seymour
Leonard Seymour Founder @ Oxford Genetics
Founder

joan-gannon_image

Joan Gannon
Joan Gannon Solutions Manager @ Oxford Genetics
Solutions Manager
2019-09-01

Founder


leonard-seymour_image

Leonard Seymour

ryan-cawood_image

Ryan Cawood

Investors List

mercia-technologies_image

Mercia Asset Management PLC

Mercia Asset Management PLC investment in Venture Round - Oxford Genetics

mercia-technologies_image

Mercia Asset Management PLC

Mercia Asset Management PLC investment in Venture Round - Oxford Genetics

invesco-perpetual-2_image

Invesco Perpetual

Invesco Perpetual investment in Venture Round - Oxford Genetics

mercia-technologies_image

Mercia Asset Management PLC

Mercia Asset Management PLC investment in Venture Round - Oxford Genetics

mercia-technologies_image

Mercia Asset Management PLC

Mercia Asset Management PLC investment in Grant - Oxford Genetics

innovate-u-k-_image

Innovate UK

Innovate UK investment in Grant - Oxford Genetics

mercia-fund-management_image

Mercia Fund Managers

Mercia Fund Managers investment in Venture Round - Oxford Genetics

mercia-fund-management_image

Mercia Fund Managers

Mercia Fund Managers investment in Seed Round - Oxford Genetics

Newest Events participated

cell-gene-therapy-bioprocessing-commercialization-2017_event_image Participated in Cell & Gene Therapy Bioprocessing & Commercialization 2017 on 2017-09-25 as exhibitor

viral-safety-2017_event_image Participated in Viral Safety 2017 on 2017-04-25 as sponsor

bioprocess-international-european-summit-2017_event_image Participated in BioProcess International European Summit 2017 on 2017-04-25 as sponsor

cell-line-development-engineering-2017_event_image Participated in Cell Line Development & Engineering 2017 on 2017-04-24 as sponsor

Official Site Inspections

http://www.oxgene.com

  • Host name: 20.49.151.14
  • IP address: 20.49.151.14
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Oxford Genetics"

OXGENE

OXGENE is the innovation arm of WuXi Advanced Therapies, providing expert design and engineering services for viral vector optimisation and cell line development, seamlessly integrated with WuXi Advanced Therapiesโ€™ GMP โ€ฆSee details»

Our People - OXGENE

Meet the people leading OXGENE's open minded, collaborative and ambitious scientific and commercial teams. Keith Meaney General Manager. Keith Meaney was appointed as General โ€ฆSee details»

OXGENE | Lab Manager

Mar 5, 2021 Organization profile for OXGENE on Lab Manager. OXGENE OXGENE, a WuXi Advanced Therapies company, accelerates the delivery of gene therapy and biologics with its โ€ฆSee details»

WuXi AppTec Completes Acquisition of OXGENE to Further โ€ฆ

Mar 1, 2021 PHILADELPHIA and OXFORD, March 2, 2021 - WuXi AppTec, a leading global provider of R&D- and manufacturing-enabling services in the pharmaceutical, biotechnology โ€ฆSee details»

OXGENE - LinkedIn

OXGENE, a WuXi Advanced Therapies (WuXi ATU) company, based in Oxford, UK, provides cell and gene therapy pioneers around the world with the technologies, automation platforms and โ€ฆSee details»

OXGENE - LinkedIn

OXGENE | 6,898 followers on LinkedIn. A WuXi Advanced Therapies company, based in Oxford, UK. | OXGENE, a WuXi Advanced Therapies (WuXi ATU) company, based in Oxford, UK, provides cell and gene therapy pioneers around the world with the technologies, automation platforms and service solutions they need to come first in the race to deliver ground-breaking โ€ฆSee details»

WuXi AppTec Completes Acquisition of OXGENE to Further โ€ฆ

Mar 2, 2021 OXGENE will become a fully-owned subsidiary of WuXi Advanced Therapies (WuXi ATU), WuXi AppTec's cell and gene therapy Contract Testing, Development and โ€ฆSee details»

OXGENE Overview | SignalHire Company Profile

Organization Website: oxgene.com : Phone Number +44 1865 415 107: OXGENE industries BiotechSee details»

OXGENE (Oxford Genetics) - VentureRadar

May 1, 2020 OXGENE find solutions to seemingly impossible problems. We develop new technologies in mammalian cell engineering along the whole spectrum from discovery science โ€ฆSee details»

Oxford Genetics - Crunchbase Company Profile

Contact Email [email protected] Phone Number +44 18 6923 8004 Oxford Genetics is a UK-based biotechnology company specializing in the production of versatile cloning plasmids for research in academic and โ€ฆSee details»

WuXi AppTec Acquires OXGENE as Its First Cell & Gene Therapy ...

Mar 11, 2021 WuXi AppTec, a leading global provider of R&D- and manufacturing-enabling services in the pharmaceutical, biotechnology and medical device industries, announced that it has completed the acquisition of OXGENE, a pioneering United Kingdom-based contract research and development organization that designs and develops scalable gene therapy technologies. โ€ฆSee details»

OXGENE

OXGENE provides an integrated solution that supports your entire discovery and validation workflow. GET IN TOUCH Are you ready for GMP Manufacture? WuXi Advanced Therapies is a global Contract Testing, Development and โ€ฆSee details»

WuXi AppTec Completes Acquisition of OXGENE to Further โ€ฆ

Mar 3, 2021 PHILADELPHIA and OXFORD, March 2, 2021 - WuXi AppTec, a leading global provider of R&D- and manufacturing-enabling services in the pharmaceutical, biotechnology โ€ฆSee details»

OXGENE Company Profile - Office Locations, Competitors, โ€ฆ

OXGENE has 5 employees across 2 locations and £1.01 m in annual revenue in FY 2018. See insights on OXGENE including office locations, competitors, revenue, financials, executives, โ€ฆSee details»

Oxgene Company Profile 2024: Valuation, Investors, Acquisition

Oxgene was founded in 2011. Where is Oxgene headquartered? Oxgene is headquartered in Oxford, United Kingdom. What is the size of Oxgene? Oxgene has 103 total employees. What โ€ฆSee details»

OXGENE - Products, Competitors, Financials, Employees, โ€ฆ

About OXGENE. OXGENE's technology platforms and solutions accelerate the discovery, development, and manufacture of cell and gene therapies. The firm provides high-titer viral โ€ฆSee details»

Oxgene Company Profile Funding & Investors | YourStory

OXGENE, a WuXi Advanced Therapies (WuXi ATU) company, based in Oxford, UK, provides cell and gene therapy pioneers around the world with the technologies, automation platforms and โ€ฆSee details»

OXGENE - The Oxford Magazine

Apr 2, 2020 OXGENE. Life Sciences. WuXi AppTec completes acquisition of Oxford-based OXGENE. This acquisition enables WuXi AppTec to offer its customers end-to-end support in โ€ฆSee details»

OXGENE

WEIHENG SU, PH.D. HEAD OF AAV, OXGENE & WuXi ATU ... WuXi Advanced Therapies is a global Contract Testing, Development and Manufacturing Organization (CTDMO) dedicated to โ€ฆSee details»